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Silver nanoparticlesAbstract Silver nanoparticles synthesized from gum kondagogu (5 nm) were used to evaluate the
antibacterial activity against Gram-positive and Gram-negative bacteria. To decipher the mode of
antibacterial action of nanoparticles, a comprehensive study was carried out employing a variety of
susceptibility assays: micro-broth dilution, antibioﬁlm activity, growth kinetics, cytoplasmic
content leakage, membrane permeabilization, etc. The production of reactive oxygen species
(ROS) and cell surface damage during bacterial nanoparticle interaction were also demonstrated
using dichlorodihydroﬂuorescein diacetate, N-acetylcysteine; and scanning electron microscopy
and energy dispersive X-ray spectra. Further, the biocompatibility with HeLa cell line was also eval-
uated. Compared to earlier reports, the minimum inhibitory concentration values were lower by
3.2- and 16-folds for Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli
strains, respectively. The minimum bactericidal concentration values were lower by 4 and 50-folds.
Thus, the biogenic silver nanoparticles were found to be more potent bactericidal agents in terms of
concentration. The nanoparticles exhibited signiﬁcant antibioﬁlm activity against test strains at
2 lg mL1, which can have implications in the treatment of drug resistant bacterial infections
caused by bioﬁlms. Growth curve in nanoparticle supplemented indicated a faster inhibition in
Gram-negative bacteria as compared to Gram-positive. Treatment with nanoparticles caused
cytoplasmic content leakage and membrane permeabilization in a dose dependent manner, an
evidence for membrane damage. The observations noted in our study substantiated the association
of ROS and membrane damage in the antibacterial action of silver nanoparticles. The promisingty, cyto-
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toxicity and its mode of action. Arabian Jouantibacterial activity enables these nanoparticles as potential bactericidal material for various
environmental and biomedical applications.
ª 2014 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The metal particles within the nano scale have properties those
are quite distinct from both the ion and the bulk material. The
strikingly different optical, electrical, magnetic, mechanical,
catalytic, thermal, chemical and biological properties at nano
scale level can be controlled by tuning the size, composition
and shape of the nanomaterials. The diverse ranges of applica-
tions shown by nanoparticles are mainly due to their smaller
particle size and large surface area (Morones et al., 2005).
An array of studies demonstrated the antibacterial of silver
nanoparticles on various bacteria (Rai et al., 2009; Sharma
et al., 2009), as an alternative approach to combat the bacterial
resistance towards conventional antibiotics (Martınez-
Castanon et al., 2008). Also, the size (Morones et al., 2005;
Sondi and Salopek-Sondi, 2004) and shape (Pal et al., 2007)
dependent antibacterial activities of silver nanoparticles have
been reported by earlier researchers. The well established
strong antimicrobial activity of silver nanoparticles on is
exploited in numerous applications including antibacterial
textiles, coatings on medical devices, etc. and in consumer
products such as cosmetics, toothpastes, laundry detergents,
soaps, home appliances, etc. Nevertheless, the antibacterial
effects of silver nanoparticles were not fully probed in a
detailed way and the manner by which they act on bacteria
is not fully understood (Dror-Ehre et al., 2009; Mohanty
et al., 2012). In this report, several integrated methodologies
were applied to study the interaction of silver nanoparticles
with the bacteria, both in planktonic and bioﬁlm modes of
growth.
The biopolymers such as gum Acacia (Mohan et al., 2007),
gum gellan (Dhar et al., 2008), carboxymethylated-curdlan,
fucoidan (Leung et al., 2010) and alginate (Pal et al., 2005)
have been utilized as reducing and stabilizing agents for metal
nanoparticle biosynthesis. The nanoparticles stabilized by
these natural polymers impart several advantages when
compared to the classic chemical methods including
biocompatibility, biodegradability; control over size, mean
diameter, size distribution, shape and dispersion of the
nanoparticles (Mohan et al., 2007; Mohanty et al., 2012; Pal
et al., 2005). In this study, we have exploited the biogenic silver
nanoparticles synthesized from gum kondagogu, a rhamnoga-
lacturonan gum (Cochlospermum gossypium) (Kora et al.,
2010) for studying the antibacterial activity and its possible
mode of action. This Indian tree gum is one of the important
non-timber forest produce from the state of Andhra Pradesh
with well characterized morphological, structural,
physicochemical, compositional, solution, conformational,
rheological, emulsifying and metal biosorption properties
(Vinod and Sashidhar, 2011).
The present study addresses the antibacterial activity of
gum kondagogu synthesized silver nanoparticles on Gram-
negative and Gram-positive bacteria. The mode of action of
silver nanoparticles on bacteria was studied in a comprehen-, Sashidhar, R.B. Biogenic silver nanop
rnal of Chemistry (2014), http://dx.doi.sive manner using various susceptibility assays including
micro-broth dilution method, antibioﬁlm activity, bacterial
growth kinetics, leakage of cytoplasmic contents, membrane
permeabilization assay, etc. The reactive oxygen species
mediated bactericidal activity of silver nanoparticles was also
demonstrated. In addition, the interaction and effect of nano-
particles on bacterial morphology was shown with scanning
electron microscopy and energy dispersive X-ray spectra.
2. Materials and methods
2.1. Synthesis and characterization of silver nanoparticles
The method for silver nanoparticles preparation using gum
kondagogu was standardized and earlier reported by us. The
silver nanoparticles were synthesized by autoclaving 0.5%
homogenous gum solution prepared from 38 lm sized gum
powder, containing 1 mM silver nitrate at 121 C and15 psi
for 60 min (Kora et al., 2010). The UV–visible absorption
spectrum (UV–vis) of the prepared nanoparticle solution was
recorded using an Elico SL 196 spectrophotometer (Hydera-
bad, India), from 250 to 800 nm, against corresponding gum
blank. The shape of the nanoparticles was obtained with a
NT-MDT Solver PRO-EC atomic force microscopy (AFM)
(Zelenograd, Russia) operating in tapping mode. A minimum
of 100 particles were counted and the size distribution and
average particle size was obtained using OriginPro 7.0 soft-
ware. The X-ray diffraction (XRD) analysis was conducted
with a Rigaku, Ultima IV diffractometer (Tokyo, Japan) using
monochromatic Cu Ka radiation (k= 1.5406 A˚) running at
40 kV and 30 mA. The intensity data for the nanoparticle solu-
tion deposited on a glass slide was collected over a 2h range of
35–70 with a scan rate of 1/min. The zeta potential of the
nanoparticle solution was assessed with a Malvern Zetasizer
Nano ZS90 (Malvern, UK).
2.2. Antibacterial assays
The Gram-negative (Escherichia coli ATCC 25922, E. coli
ATCC 35218, Pseudomonas aeruginosa ATCC 27853) and
Gram-positive (Staphylococcus aureus ATCC 25923) bacteria
were used as model test strains for checking the antibacterial
activity and mode of action of silver nanoparticles. The absor-
bance and ﬂuorescence measurements were carried out with
Biotek Synergy H1 plate reader (Winooski, Vermont,
USA). The minimum inhibitory concentration (MIC) and min-
imum bactericidal concentration (MBC) of silver nanoparticles
against test bacterial strains was investigated with micro-broth
dilution method (Hernandez-Sierra et al., 2008; Martınez-
Castanon et al., 2008). The effect of silver nanoparticles on
bioﬁlm formation was monitored with a modiﬁed microtiter
plate assay (Uhlich et al., 2006). The bacterial growth curve
in nanoparticle supplemented media was monitored for 48 h
(Sondi and Salopek-Sondi, 2004; Venkatpurwar andarticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
org/10.1016/j.arabjc.2014.10.036
Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum 3Pokharkar, 2011). The effect of silver nanoparticles on
membrane damage was studied by quantifying the leaked cyto-
plasmic nucleic acids and proteins (Chen and Cooper, 2002;
Liu et al., 2004; Tiwari et al., 2008). The outer membrane
damage in Gram-negative bacteria induced by silver nanopar-
ticles was monitored using a ﬂuorescent probe, N-phenyl
naphthylamine (NPN) permeabilization assay (Helander and
Mattila-Sandholm, 2000; Liu et al., 2004). To ﬁnd out the pos-
sible involvement of free radicals in the bactericidal activity of
nanoparticles, the antioxidant N-acetylcysteine (NAC) was
used (Kim et al., 2007). The generation of intracellular reactive
oxygen species (ROS) generation in nanoparticle treated bacte-
rial cells was determined using a common ﬂuorescent dye
dichlorodihydroﬂuorescein diacetate (H2DCFDA), an
intracellular ROS indicator (Choi and Hu, 2008). In order to
elucidate the antibacterial mode of silver nanoparticles, scan-
ning electron microscopy (SEM) technique was used (Sondi
and Salopek-Sondi, 2004). For evaluating the cytotoxicity of
prepared nanoparticles on mammalian cells, the 3-(4,5-
Dimethyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
was carried out with human cervical cancer cell line HeLa
(Cao et al., 2010). The detailed information on various assays
is given in Appendix A. All the experiments were carried out in
triplicate and the data were presented as mean ± standardFigure 1 (a) UV–vis spectrum, Inset: color of the reaction mixture
topographic image, Scan scale 10 · 10 lm; height scale 10 nm, (c) XRD
synthesized from gum.
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Student’s t-test.
3. Results and discussion
3.1. Characterization of silver nanoparticles
After autoclaving, the appearance of yellow color in the reac-
tion mixture indicated the formation of silver nanoparticles by
the gum, a dual functional reductant and stabilizer. In the UV–
vis spectrum a single strong peak with a maximum at 408 nm
was observed, which corresponds to the typical surface plas-
mon resonance of silver nanoparticles [Fig. 1(a)]. From the
AFM image, it was found that the nanoparticles are spherical
in shape, polydisperse and the average particle size was about
4.5 ± 3.1 nm [Fig. 1(b)]. The XRD pattern of the silver
showed characteristic diffraction peaks at 38.2, 44.2 and
64.4, respectively, corresponding to (111), (200) and (220)
planes of face centred cubic (fcc) crystal structure of metallic
silver. In addition, the broadening of the diffraction peaks sug-
gested the effect of nano-sized particles [Fig. 1(c)]. The highly
stable nature of the produced colloids was also conﬁrmed from
the measured zeta potential value of 32.7 ± 3.8 mV
[Fig. 1(d)].(a) before and (b) after autoclaving, (b) two dimensional AFM
pattern and (d) zeta potential distribution of silver nanoparticles
articles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
org/10.1016/j.arabjc.2014.10.036
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The biocidal nature of silver nanoparticles is determined by the
size and stability of the produced colloids (Choi and Hu, 2008;
Martınez-Castanon et al., 2008; Morones et al., 2005;
Siddhartha et al., 2007; Tiwari et al., 2008). The bactericidal
action of 5 nm sized silver nanoparticles produced with gum
kondagogu against Gram-negative and Gram-positive bacteria
was studied in detailed employing diverse susceptibility assays.
The growth inhibition effect of silver nanoparticles against
bacteria was measured by MIC and MBC (Table 1). For the
bacterial strains S. aureus 25923, P. aeruginosa 27853, E. coli
25922 and E. coli 35218, the MIC values of silver nanoparticles
were 10.0, 5.0, 2.0 and 2.0 lg mL1, respectively. In a previous
antibacterial study, MIC values of 8–32, 16 and 32 lg mL1
were reported for S. aureus, P. aeruginosa and E. coli strains,
respectively. These nanoparticles of 13 nm size were prepared
using culture supernatant of P. aeruginosa (Kumar and
Mamidyala, 2011). For the respective S. aureus, P. aeruginosa
and E. coli strains, the MIC values were lower by 3.2, 3.2 and
16-folds. Thus, the silver nanoparticles synthesized using plant
gum was found to be a more potent bactericidal agent in terms
of concentration. The highest value of MIC was noted for S.
aureus 25923 27853 followed by P. aeruginosa. Most of the
MBC values of silver nanoparticles were same as MIC except
for P. aeruginosa and S. aureus 25923, in which higher MBC
values were observed. The MBC values detected for S. aureus
and E. coli strains are lower by 4 and 50-folds, respectively;
when compared to PVP stabilized nanoparticles of 10 nm size
synthesized by ultrasonic irradiation (Cho et al., 2005). The
lowest values of MIC and MBC were observed for both the
E. coli strains. From the results, it is clear that among
the strains selected for testing, E. coli was more susceptible
towards the bactericidal activity of biogenic silver
nanoparticles used in this study. These ﬁndings on susceptibil-
ity of E. coli towards silver nanoparticles are in similar lines
with earlier reported studies (Cho et al., 2005; Kim et al., 2007;
Martınez-Castanon et al., 2008).
3.3. Antibioﬁlm activity
The inhibition of bioﬁlm formation of test strains by silver
nanoparticles was studied with static microtiter plate assay atTable 1 MIC and MBC values observed for silver nanoparticles ag
Parameter Bacterial strains
S. aureus 25923 P. aerug
MIC (lg mL1)a 10.0 5.0
MBC (lg mL1)a 12.0 12.0
a Values are mean for n= 3; CV 6 5%.
Table 2 The % inhibition in bioﬁlm formation by different bacteri
Test compound (lg mL1) Bioﬁlm inhibition (%)a
S. aureus 25923 P. a
Silver nanoparticles (2) 66.3 ± 1.3 73.7
Ciproﬂoxacin (0.1) 73.0 ± 0 39.4
a Values are mean ± SD for n= 3.
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cles were able to impede the bioﬁlm formation in E. coli strains
25922 and 35218 by 83.9% and 93.1%, respectively. In the case
of S. aureus 25923 and P. aeruginosa 27853, the nanoparticles
were able to prevent the bioﬁlm formation on the plate surface
by 66.3% and 73.7%, respectively. These results are in line
with an earlier antibioﬁlm studies carried out using starch
stabilized silver nanoparticles (Mohanty et al., 2012) and silver
nanoparticles synthesized using Bacillus licheniformis
(Kalishwaralal et al., 2010); against P. aeruginosa and S. aur-
eus 25923 and P. aeruginosa and S. epidermidis, respectively.
Among the selected strains, S. aureus 25923 and P. aerugin-
osa 27853 were known to produce exopolysaccharides, which
are needed for the adhesion of bacterial cells to the surface
during bioﬁlm formation (Mohanty et al., 2012). The ability
to form bioﬁlms is one of important factor involved in the
establishment of the infection. Though P. aeruginosa does
not cause infection in healthy individuals, it is emerging as
an opportunistic pathogen in immunocompromised humans
(May et al., 1991). Interestingly, the activity of silver nanopar-
ticles against P. aeruginosa 27853 bioﬁlm formation was nearly
2-fold as compared to the positive control ciproﬂoxacin. The
observations found in this study are very signiﬁcant as both
povidone–iodine and chlorhexidine were shown to be ineffec-
tive against bioﬁlms of P. aeruginosa (Stickler and Hewett,
1991). The results indicate that the biogenic silver nanoparti-
cles synthesized from the plant gum demonstrate strong
bactericidal activity as well as antibioﬁlm activity which can
have implications in the treatment of drug resistant bacterial
infections caused by bioﬁlms and biofouling control.
3.4. Bacterial growth kinetics in the presence of nanosilver
The growth inhibition of bacteria was checked in nutrient
broth supplemented with different concentrations of nanopar-
ticles (1–10 lg mL1), for 48 h at 600 nm. The growth curves
are depicted for the untreated and silver nanoparticle treated
bacteria to indicate the time dependent changes in bacterial
growth. The kinetics of the all the growth curves obey typical
pattern; a lag phase, an exponential phase and a stationary
phase for the untreated and silver nanoparticle treated bacteria
(Fig. 2). The growth of bacterial strains was inhibited progres-
sively with increase in concentration of nanoparticles. At theainst different bacterial strains.
inosa 27853 E. coli 25922 E. coli 35218
2.0 2.0
2.0 2.0
al strains treated with silver nanoparticles and ciproﬂoxacin.
eruginosa 27853 E. coli 25922 E. coli 35218
± 0.3 83.9 ± 0.2 93.1 ± 0.4
± 3.5 83.1 ± 0 93.3 ± 0.6
articles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
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Figure 2 Growth curve of bacteria in nutrient broth supplemented with different concentrations (1–10 lg mL1) of silver nanoparticles,
(a) E. coli 25922, (b) E. coli 35218, (c) P. aeruginosa 27853 and (d) S. aureus 25923.
Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum 5concentrations beyond 1 lg mL1, the lag phase was contin-
ued for 8 h for the strain E. coli 25922. After 24 h of incuba-
tion, the growth was resumed at 2, 3, 4 and 5 lg mL1 and a
concentration of 10 lg mL1 completely inhibited the growth
[Fig. 2(a)]. But in an earlier report with 10–15 nm sized silver
nanoparticles, even a higher concentration of 25 lg mL1
enhanced the lag phase about 8 h only for E. coli 25922
(Siddhartha et al., 2007).
In the case of another Gram-negative E. coli 35218 strain, all
the concentration tested (1–10 lg mL1) prolonged the lag
phase for 8 h. The growth was resumed for concentrations of
1–2 lg mL1 and 3–5 lg mL1 after 8 and 24 h, respectively
and a concentration of 10 lg mL1 completely inhibited the
cellular division [Fig. 2(b)]. In an earlier antibacterial character-
ization study carried out with silver nanoparticles of 16 nm size
against another E. coli strain ATCC 15224, no bacterial growth
was noted at 60 lg mL1 concentration (Rafﬁ et al., 2008). But
such phenomenon of complete inhibition was observed at
10 lg mL1 concentration itself with gum reduced silver nano-
particles against E. coli 35218. With the same strain of E. coli
35218 and polylysine capped silver nanoparticles of 7.2 nm size,
a concentration of 50 lg mL1 only prolonged the lag phase for
5 h (Dror-Ehre et al., 2009). For P. aeruginosa 27853, the con-
centrations of 1–2 and 3–5 lg mL1 of nanoparticles extended
the lag phase for 8 h and 24 h, respectively. At a concentration
of 10 lg mL1, the growth was arrested completely [Fig. 2(c)].
In the case of Gram-positive S. aureus 25923, 3–10 lg mL1
of silver nanoparticles caused a lag phase for 8 h and beyond
which growth was continued for 24 h and reached stationaryPlease cite this article in press as: Kora, A.J., Sashidhar, R.B. Biogenic silver nanop
toxicity and its mode of action. Arabian Journal of Chemistry (2014), http://dx.doi.phase at 48 h [Fig. 2(d)]. With the same strain of S. aureus
25923, the concentration of 100 lg mL1 elicited only a partial
growth inhibition with silver nanoparticles 10–15 nm synthe-
sized with glucose and hydrazine (Siddhartha et al., 2007). With
time, the concentration of nanoparticles decreases as a result of
coagulation and removal during the interaction of nanoparti-
cles with intracellular substances of the destroyed cells (Sondi
and Salopek-Sondi, 2004). As a consequence, the bacterial cells
resume the growth after 8 h due to a reduction in the effective
concentration of nanoparticles. The bacterial cultures without
nanoparticles did not show any inhibition and reached the
stationary phase at the end of 48 h. The enhanced growth inhi-
bition activity of the nanoparticles used here can be attributed
to superior stability of the nanoparticle solutions (Siddhartha
et al., 2007). The data on growth curve indicates a faster inhibi-
tion in Gram-negative bacteria compared to Gram-positive
bacteria. In earlier studies on time and dose dependent antibac-
terial potential of silver nanoparticles, similar observations
were noted with E. coli and B. subtilis (Tiwari et al., 2008);
and E. coli and S. aureus strains (Siddhartha et al., 2007;
Venkatpurwar and Pokharkar, 2011). The results conclusively
suggest that the inhibition of growth depends upon the type
of bacterial strain as well as concentration and particle size of
the nanoparticles.
3.5. Leakage of cytoplasmic contents
As reported in literature, the leakage of cytoplasmic contents is
a characteristic feature for indicating the damage to thearticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
org/10.1016/j.arabjc.2014.10.036
Figure 3 Release of (a) 260 nm and (b) 280 nm absorbing materials from the cell suspensions of bacteria treated with silver nanoparticle
solutions. Values are mean ± SD for n= 3; **p< 0.005, ***p< 0.001 and ****p< 0.0001 compared to negative control.
Figure 4 Uptake of NPN in bacteria induced by treatment with
silver nanoparticle solutions. Values are mean ± SD for n= 3;
****p< 0.0001 compared to negative control.
Figure 5 Petri plates showing the effect of antioxidant NAC on t
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Due to the interaction of nanoparticles with cells, the cell mem-
brane looses its integrity leading to the release of intracellular
contents such as nucleic acids and nucleotides; and proteins
by membrane disruption (Fig. 3). Thus, the occurrence of these
substances signiﬁes the membrane damage. With an increase in
nanoparticle concentration, the amount of nucleic acids and
proteins released from the cells increased in a dose dependent
manner. The enhancement suggests the rapid reaction kinetics
of the nanoparticles with bacterial cells. These results are in line
with previous reports (Tiwari et al., 2008). At 5 lg mL1
concentration of nanoparticles, the highest release of nucleic
acids and proteins was observed with E. coli 25922, followed
by P. aeruginosa 27853, E. coli 35218 and S. aureus 25923. In
comparison with other Gram-negative strains, the Gram-posi-
tive S. aureus 25923 was found to be more resistant towards the
nanoparticle mediated membrane damage [Fig. 2]. These obser-
vations are similar to the earlier antibacterial studies carried
out with E. coli DH5a and B. subtilis strains (Tiwari et al.,
2008). Hence, the results indicated the release of intracellular
components, an evidence for membrane damage.he bactericidal activity of silver nanoparticles on E. coli 25922.
articles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
org/10.1016/j.arabjc.2014.10.036
Figure 6 Bar graph showing the% of viable cells in the presence
of antioxidant NAC and 5 lg mL1 of silver nanoparticles. Values
are mean ± SD for n= 3; **p< 0.005, ***p< 0.001 and
****p< 0.0001 compared to control.
Figure 7 Production of intracellular ROS in the bacterial cell
suspensions treated with silver nanoparticles. Values are
mean ± SD for n= 3; **p< 0.005 and ****p< 0.0001 compared
to negative control.
Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum 73.6. Outer membrane damage
An intact outer membrane acts as permeability barrier and
excludes hydrophobic substances such as NPN. But once
damaged, it can allow the entry of hydrophobic agents such
as NPN to the phospholipid layer of outer membrane, result-
ing in prominent characteristic ﬂuorescence. This is mainly due
to the destabilizing interaction of nanoparticles with mem-
brane components (Helander and Mattila-Sandholm, 2000).
The bacterial cell suspensions treated with silver nanoparticles
exhibited outer membrane damage in a dose dependent man-
ner (Fig. 4). These ﬁndings are in agreement with studies on
bactericidal activity of chitosan against E. coli (Liu et al.,
2004). From the data it is apparent that among the Gram-
negative strains, E. coli 35218 was least susceptible to the outer
membrane permeabilization activity of silver nanoparticles.
Even with less sensitive E. coli 35218, the activity of thePlease cite this article in press as: Kora, A.J., Sashidhar, R.B. Biogenic silver nanop
toxicity and its mode of action. Arabian Journal of Chemistry (2014), http://dx.doi.nanoparticles was higher at both the tested concentrations of
2 and 3 lg mL1, when compared to the positive control
hydrogen peroxide (Fig. 4).
3.7. Effect of antioxidant on the bactericidal activity of silver
nanoparticles
For studying the involvement of ROS in the antibacterial
effect of silver nanoparticles, NAC was used as an antioxidant.
In the control petriplates with NAC alone at 10 mM concen-
tration, the bacterial colonies were clearly seen with no growth
inhibition. However, in the petriplates supplemented with
5 lg mL1 of nanoparticles, no bacterial colonies were
observed due to complete inhibition of growth. While, the
petriplates supplemented with both NAC and silver nanopar-
ticles, the bacterial colonies were observed (Fig. 5). From these
photographs, it is clearly evident that NAC acted as a free
radical scavenger and protected the bacterial cells from the
bactericidal activity of silver nanoparticles.
The % survival of bacteria in the presence of NAC and sil-
ver nanoparticles is depicted in Fig. 5. For the Gram-positive
S. aureus 25923 and Gram-negative E. coli 35218, NAC was
able to protect the 100% and 89.3% of bacterial cells from
the toxicity of the silver nanoparticles at 5 lg mL1. Hence,
S. aureus 25923 and E. coli 35218 were resistant to the
bactericidal activity of silver nanoparticles. But, NAC was able
to protect only 77.9% and 37.1% of cells from silver nanopar-
ticles, for P. aeruginosa 27853 and E. coli 25922, respectively
(Fig. 6). It indicates that these strains were not able to recover
completely from the bactericidal activity of silver nanoparti-
cles, even with NAC supplementation. The effective bacterici-
dal activity of biogenic nanoparticles on E. coli 25922 and P.
aeruginosa 27853 could be due to an increase in the bioavail-
ability of the silver nanoparticles by gum kondagogu. The
gum kondagogu is known to improve the bioavailability of
the drug and the same is reported for the controlled release
of diclofenac sodium (Naidu et al., 2009).
The experimental data of the present study suggests that
probably ROS are involved in the bactericidal activity of silver
nanoparticles and these scavengers prevented this effect by
interacting with the ROS. This observation is in concurrence
with earlier studies on antimicrobial effects of silver nanopar-
ticles (Kim et al., 2007; Kora and Arunachalam, 2011) and
ZnO and TiO2 nanoparticles (Inoue et al., 2002). As suggested
by the previous researchers, our ﬁndings support the genera-
tion of free radicals from the surface of silver nanoparticles
and inhibition of bacterial growth.
3.8. Detection of intracellular ROS
The levels of ROS are used as a collective marker for superox-
ide anion, hydroxyl radical and hydrogen peroxide, which act
as an indicator for cellular oxidative stress. Hence, the produc-
tion of intracellular ROS was monitored with H2DCFDA by
studying the response of bacterial strains towards silver
nanoparticles (Fig. 7). For the bacterial strains S. aureus
25923 and E. coli 25922, the generation of intracellular ROS
is comparable with positive control 30 lMH2O2, at 2 lg mL
1
of nanoparticles (Fig. 7). In the case of P. aeruginosa 27853
and E. coli 35218, the intracellular ROS was more than the
positive control (Fig. 7). The tolerance of P. aeruginosaarticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
org/10.1016/j.arabjc.2014.10.036
Figure 8 SEM photographs of bacterial cells at 200 nm scale. Cells of S. aureus (a) before and (b) after treatment; and P. aeruginosa
27853 (c) before and (d) after treatment with 5 lg mL1 of silver nanoparticles.
Figure 9 EDX spectra of bacteria, S. aureus (a) before and (b) after treatment; and P. aeruginosa 27853 (c) before and (d) after treatment
with 5 lg mL1 of silver nanoparticles.
8 A.J. Kora, R.B. Sashidhartowards H2O2 can be attributed to the protective role of con-
stitutively expressed catalase enzyme (Elkins et al., 1999).
Among the selected strains, the ROS generation was highestPlease cite this article in press as: Kora, A.J., Sashidhar, R.B. Biogenic silver nanop
toxicity and its mode of action. Arabian Journal of Chemistry (2014), http://dx.doi.with S. aureus 25923. Thus, the production of intracellular
ROS during the interaction of silver nanoparticles with bacte-
ria are consistent with the previous studies on the involvementarticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
org/10.1016/j.arabjc.2014.10.036
Figure 10 Proposed mode of antibacterial action of silver nanoparticles demonstrated with various susceptibility assays.
Figure 11 Eeffect of silver nanoparticles on the cell viability of
HeLa cell line at various concentrations. Values are mean ± SD
for n= 3; **p< 0.005, ***p< 0.001 and ****p< 0.0001 com-
pared to untreated cells.
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ZnO and TiO2 nanoparticles (Kumar et al., 2011).
3.9. Effect of nanoparticles on bacterial morphology
The effect of 5 lg mL1 concentration of silver nanoparticles
on the cell surface morphology of the Gram-positive S. aureus
25923 and Gram-negative P. aeruginosa 27853 strains was
investigated using SEM technique (Fig. 8). In the untreated
samples, the spherical and rod shaped cells of S. aureus and
P. aeruginosa were clearly seen. When compared to the
controls, the micrographs of the treated samples reveal the
attachment of nanoparticles to the surface of bacterial cells.
And after treatment, structural changes in the bacteria
morphology such as cell surface damage were clearly observed
and resulted in the formation of cell debris by majority of the
bacterial cells. Additionally, the existence of elemental silver in
the membrane was also conﬁrmed from the EDX spectra of
the treated bacteria. These samples exhibit a strong absorptionPlease cite this article in press as: Kora, A.J., Sashidhar, R.B. Biogenic silver nanop
toxicity and its mode of action. Arabian Journal of Chemistry (2014), http://dx.doi.peak at 3 keV, which corresponds to the characteristic absorp-
tion of silver nanoparticles due to surface plasmon resonance
(Fig. 9). These results are in concurrence with the earlier anti-
bacterial studies carried out with silver nanoparticles (Cho
et al., 2005; Sondi and Salopek-Sondi, 2004).
3.10. Proposed mode of antibacterial action
The antibacterial activity of silver nanoparticles was visualized
with susceptibility assays and quantiﬁed in terms of MIC,
MBC and inhibition of growth kinetics. The antibioﬁlm activ-
ity was calculated via in vitro microtiter plate crystal violet
assay. The membrane damage was measured through UV–vis
absorption and NPN. The involvement of ROS in bactericidal
activity of silver nanoparticles was demonstrated via antioxi-
dant assay and the generation of intracellular ROS was
detected via ﬂuorescent dye H2DCFDA. The damage to cell
surface morphology by nanoparticles is shown in SEM
(Fig. 10). Based on the results, we tend to speculate that the
ROS may be generated from the surface of silver nanoparti-
cles; interact with the cell wall and membrane, damage the cell
membrane, increase the cell permeability and leak the
intracellular contents such as proteins and nucleic acids by cell
disruption. In turn, the interaction of bacteria with nanoparti-
cles also causes structural and morphological changes and cell
surface damage. The observations noted in our study substan-
tiate the association of ROS and cell membrane damage in the
antibacterial action of silver nanoparticles. These observations
conﬁrm the earlier ﬁndings on the antibacterial mechanism of
silver nanoparticles (Cho et al., 2005; Kim et al., 2007;
Morones et al., 2005; Rafﬁ et al., 2008; Sondi and Salopek-
Sondi, 2004). However, we believe that the mode of action
of silver nanoparticles on bacteria is probably more complex
than assumed, involving more than one mechanism and a
series of events, ﬁnally leading to cell death.
3.11. Cytotoxicity evaluation
The biocompatibility of the nanoparticles was evaluated with
HeLa cell line for ﬁnding out their applications in biomedical
ﬁeld. The MTT assay assesses the mitochondrial activity by
measuring the ability of viable cells to reduce MTT into purple
formazon product. The % viability of the cells was plottedarticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cyto-
org/10.1016/j.arabjc.2014.10.036
10 A.J. Kora, R.B. Sashidharagainst various nanoparticle concentrations at different time
intervals. The concentrations of silver nanoparticles up to
2.5 lg mL1 were not cytotoxic. Beyond the concentration of
2.5 lg mL1, they were cytotoxic. After 72 h of incubation,
the cell viability was dropped drastically to 54% and 18.2%
at 5 lg mL1 and 10 lg mL1, respectively (Fig. 11). Most of
the previously reported cytotoxic studies with silver nanoparti-
cles were carried out for 24 h only (Mohanty et al., 2012;
Valodkar et al., 2011). With silver nanoparticles of 5–10 nm
(Miura and Shinohara, 2009) and 10 nm (Valodkar et al.,
2011) size, the cytotoxicity was noted at 100 lg mL1 and
50 lg mL1, respectively at 24 h. In the case of silver nanopar-
ticles produced with garlic clove extract, the studies were
extended for 48 h (Ahamed et al., 2011). While in our study,
we have investigated the anti-proliferation effect of 4.5 nm
sized plant gum synthesized silver nanoparticles for 24–72 h.
It can be inferred from these results that there is a dependency
of cytotoxic concentration on particle size. These results are in
tune with earlier studies carried out with cytotoxic activities of
chitosan nanoparticles of different sizes (Qi et al., 2005). Based
on the observations, it can be inferred that nanoparticles with
enhanced toxicity may be employed as bactericidal agents,
while benign biocompatible ones as drug delivery and labeling
agents (Suresh et al., 2010).
4. Conclusion
The biogenic silver nanoparticles synthesized using gum
kondagogu was found to be a more potent bactericidal agent
in terms of MIC and MBC, compared to previous reports.
The nanoparticles exhibited signiﬁcant antibioﬁlm activity
against test strains and the growth curve of bacteria in nano-
particle supplemented media indicated a faster inhibition in
Gram-negative bacteria compared to Gram-positive bacteria.
Also, the nanoparticle treatment caused morphological
changes, cell surface damage and leakage of cytoplasmic con-
tents. The observations noted in this comprehensive study sub-
stantiate the association of ROS and cell membrane damage in
the antibacterial action of silver nanoparticles. However, fur-
ther studies are needed to ﬁnd out the actual intracellular
and cell surface target molecules in bacteria. The promising
antibacterial activity enables these nanoparticles as potential
bactericidal material for various environmental and
biomedical applications such as antibacterial food packaging
materials, antibacterial textiles, water puriﬁcation ﬁlters,
antibacterial paints wound dressings, topical antibacterial gels,
etc. In view of this, further cytotoxicity studies are needed with
different cell lines to represent the interaction between nano-
particles and mammalian cells.
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